Healthstream (HSTM) FY2015 results: revenue $209 million, up 22.4% on the year
Healthstream Inc. (HSTM) reported revenue of $209 million for fiscal 2015, the year ended 31 December 2015, up 22.4% on the year before. Net income was $9 million, down 17.1%, and diluted earnings per share $0.28. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2016.
Revenue
$209 million
+22.4% on the year
FY2009FY2015
Operating margin
6.5%
9.6% a year earlier
FY2009FY2015
Net income
$9 million
-17.1% on the year
FY2009FY2015
Diluted EPS
$0.28
-24.3% on the year
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
209
171
132
+22.4%
Research and development
24.2
16.5
11.8
+47.1%
Operating income
13.6
16.4
14.7
-17.2%
Operating margin
6.5%
9.6%
11.1%
Pre-tax income
13.7
16.5
14.8
-17.0%
Income tax
5.1
6.1
6.4
-16.8%
Effective tax rate
37.2%
37.1%
43.3%
Net income
8.6
10.4
8.4
-17.1%
Net margin
4.1%
6.1%
6.4%
Diluted EPS
$0.28
$0.37
$0.30
-24.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
34.9
34.3
26.3
+1.9%
Capital expenditure
8.1
4.5
4.4
+78.1%
Free cash flow
26.8
29.7
21.8
-9.7%
Free cash flow margin
12.8%
17.4%
16.5%
Cash from investing
n/a
n/a
-15.0
Cash from financing
n/a
n/a
6.9
Depreciation and amortisation
17.0
10.9
7.9
+55.5%
Share-based compensation
3.3
1.6
1.5
+101.8%
Diluted shares, weighted
30m
28m
28m
+8.6%
Shares outstanding at period end
32m
28m
27m
+14.3%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
280
168
149
+67.0%
Debt
0.0
0.0
0.0
Other liabilities
99.2
89.4
63.2
+11.0%
Total liabilities and equity
380
257
213
+47.5%
Fixed assets
12.5
9.4
9.0
+32.1%
Goodwill
83.1
41.9
35.7
+98.2%
Intangible assets
56.0
14.8
8.9
+278.3%
Investments
67.0
39.0
n/a
+71.9%
Cash and equivalents
82.0
82.0
59.5
+0.0%
Receivables
36.3
33.2
25.3
+9.6%
Other assets
42.7
37.0
74.1
+15.5%
Total assets
380
257
213
+47.5%
10-K for the year ended 31 December 2015, filed 26 February 2016: the filing.